AZD6234
SELENE 1
AstraZeneca · Phase 3 · Recruiting · Enrollment 2500
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| AZD6234 Dose 1 | Obesity or overweight | n/r | 68 | n/r | n/r |
| AZD6234 Dose 2 | Obesity or overweight | n/r | 68 | n/r | n/r |
| Placebo | Obesity or overweight | n/r | 68 | n/r | n/r |